Replimune Group: Of This Current Report On Form 8k, Including Exhibit 99.1, Shall Not Be Deemed “filed” For The Purposes Of Section 18 Of Thesecurities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference In Any Filing Under Thesecurities Act Of 1933, As Amended, Or Theexchange Act, Except As Expressly Stated By Specific Reference In Such Filing, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Financial Statements And Exhibits
| Den gesamten Artikel anzeigen |
|
Diese Funktion ist nur für autorisierte Benutzer verfügbar
|
-
Vollständiger NameReplimune Group, Inc.
-
EintragungslandUSA
-
BranchePharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***